JSC Pharmasyntez
The history of the Pharmasyntez Group of Companies began in 1997 with the construction of a pharmaceutical plant for the production of anti-TB drugs in Irkutsk. It was there that the company's first drugs were produced. In 2009, the plant was completely modernized; a small-scale production department opened in 2017, and a solid sterile dosage form department was launched in January 2021.
It is not only a large manufacturing site but also a robust research center.
LEONID NIKOLAEVICH CHEREPANOV
Acting Chief Executive Officer of Pharmasyntez, JSC
The Irkutsk plant produces:
Anti-COVID, anti-TB, antiviral, antineoplastic, antifungal drugs, sterile dosage forms, antibiotics.
Dosage forms
Tablets
Capsules
Granules
Ampules
Vials
Prefilled syringes
Cartridges
Tubes (gels, ointments, creams)
Suppositories
Solid dosage forms
- tablets – 7 lines
- capsules – 2 lines
- granules – 1 line
Sterile dosage forms
- solutions for injection – 1 line
- sterile powders for solution for injection – 2 lines
- prefilled syringes and cartridges – 1 line/li>
- glass ampules – 1 line
- lyophilized products, solutions, concentrates – 2 lines
Soft dosage forms
- oral solutions – 1 line
- tubes (gels, ointments, creams) – 1 line
- suppositories – 1 line
R&D Department
Works with all finished dosage forms, including prefilled syringes and cartridges:
- development of innovative and generic drugs
- search of new molecules for the treatment of tuberculosis and HIV/AIDS, oncology diseases
- Investment of 500 million RUB per year
